marijuana stocks

Form 8-K for MEDBOX, INC.


12-Nov-2015

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

Item 1.01 Entry into a Material Definitive Agreement.On November 4, 2015, Medbox, Inc. (the “Company”) entered into a certain Joint Venture Agreement (the “Agreement”) with Mark Marsh (“Marsh”) as an independent contractor to provide cultivation services for the Company. The Agreement has an initial term of five years. Marsh is to cultivate hemp outdoors and in greenhouses at the Company’s farmland located at 214 39th Lane, Pueblo, Colorado. The proceeds from sale of products related to the outdoor cultivation, after direct expenses, shall be distributed 90% to the Company and 10% to Marsh. The proceeds from the sale of products related to the greenhouse cultivation, after direct expenses, shall be distributed 99% to the Company and 1% to Marsh.

On November 10, 2015, the Company issued a press release announcing the signing of the Agreement. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

 

Item 9.01 Financial Statements and Exhibits.(d) Exhibits

                 Exhibit
                 Number    Description

                 99.1      Press Release dated November 10, 2015.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Aurora Cannabis Inc. (ACB) Announces the Completion of a Multimillion Dollar Investment and Renaming of B.C. Manufacturing Facility

Aurora Cannabis Announces the Completion of a Multimillion Dollar Investment and Renaming…

$RMHB Acquire Upstate New York Facility as a Bottling Plant

Rocky Mountain High Brands to Acquire Upstate New York Facility as a…

 Green Thumb Industries Inc (GTBIF) to Hold Third Quarter 2020 Earnings Conference Call

Green Thumb Industries to Hold Third Quarter 2020 Earnings Conference Call on…

AbbVie Inc. (ABBV) to Present Extensive Data from its Migraine Portfolio at the 2022 American Headache Society®

AbbVie to Present Extensive Data from its Migraine Portfolio at the 2022…